Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Long-Term Mortality and Left Ventricular Function in Patients After Primary Percutaneous Coronary Intervention

JACC: Cardiovascular Interventions

Volumn 2, Issue 11, 2009, Pages 1128-1134

  Claessen, Bimmer E P M ^a   van der Schaaf, René J ^a   Verouden, Niels J ^a   Stegenga, Nienke K ^a   Engstrom, Annemarie E ^a   Sjauw, Krischan D ^a   Kikkert, Wouter J ^a   Vis, Marije M ^a   Baan Jr , Jan ^a   Koch, Karel T ^a   de Winter, Robbert J ^a   Tijssen, Jan G P ^a   Piek, Jan J ^a   Henriques, José P S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

chronic total occlusion; left ventricular function; mortality; myocardial infarction; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DETERIORATION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; SURVIVAL RATE; SURVIVOR;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHRONIC DISEASE; COHORT STUDIES; CORONARY OCCLUSION; CORONARY STENOSIS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 70449501060     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.08.024     Document Type: Article

References (19)

1. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
2. Moreno R., Conde C., Perez-Vizcayno M.J., et al. Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention. J Invasive Cardiol 18 (2006) 16-19
3. Sanz G., Castaner A., Betriu A., et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 306 (1982) 1065-1070
4. van der Schaaf R.J., Vis M.M., Sjauw K.D., et al. Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol 98 (2006) 1165-1169
5. van der Schaaf R.J., Timmer J.R., Ottervanger J.P., et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart 92 (2006) 1760-1763
6. Pfeffer M.A., Braunwald E., Moye L.A., et al., SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327 (1992) 669-677
7. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) 671-719
8. Di Mario C., Mara S., Flavio A., et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 6 (2004) 128-133
9. Ochala A., Smolka G.A., Wojakowski W., et al. The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction. J Invasive Cardiol 16 (2004) 699-702
10. Ambrose J.A., and Weinrauch M. Thrombosis in ischemic heart disease. Arch Intern Med 156 (1996) 1382-1394
11. Barrett T.D., Hennan J.K., Marks R.M., and Lucchesi B.R. C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion. J Pharmacol Exp Ther 303 (2002) 1007-1013
12. Marenzi G., Lauri G., Assanelli E., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785
13. Chen L.Y., Lennon R.J., Grantham J.A., et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol 95 (2005) 349-354
14. Corpus R.A., House J.A., Marso S.P., et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 148 (2004) 493-500
15. Rigattieri S., Biondi-Zoccai G., Silvestri P., et al. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. J Interv Cardiol 21 (2008) 1-7
16. Kalarus Z., Lenarczyk R., Kowalczyk J., et al. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J 153 (2007) 304-312
17. Varani E., Balducelli M., Aquilina M., et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc Interv 72 (2008) 927-933
18. Henriques J.P., and van der Schaaf R.J. EXPLORE trial register. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1108 Accessed April 14, 2009
19. Hanratty C.G., Koyama Y., Rasmussen H.H., Nelson G.I., Hansen P.S., and Ward M.R. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol 40 (2002) 911-916